DAFNA Capital Management LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1389933 LOS ANGELES, CA

Position in SPRY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,118,458

-$1,095,799 QoQ

Shares Held

139,285

-26.7% QoQ

Ownership

0.140%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

DAFNA Capital Management LLC holds $266,800,868 across 59 Biotechnology names. SPRY ranks #39 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	580,678	$56,470,935
2	DAWN	Day One Biopharmaceuticals, Inc.	978,463	$20,978,246
3	IDYA	IDEAYA Biosciences, Inc.	476,740	$15,884,976
4	XENE	Xenon Pharmaceuticals Inc.	250,772	$14,582,391
5	CYTK	Cytokinetics Inc	217,497	$14,335,227
6	NKTR	Nektar Therapeutics	165,178	$11,884,557
7	RCUS	Arcus Biosciences, Inc.	443,829	$9,586,706
8	LRMR	Larimar Therapeutics, Inc.	2,029,164	$9,131,238

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,118,458	139,285	-26.7%	Shares	Sole	2026-05-15
2025-12-31	$2,214,257	190,065	+35.3%	Shares	Sole	2026-02-17
2025-09-30	$1,412,025	140,500	+47.4%	Shares	Sole	2025-11-14
2025-03-31	$1,198,748	95,290	+7.3%	Shares	Sole	2025-05-15
2024-12-31	$936,734	88,790	-40.1%	Shares	Sole	2025-02-14
2024-09-30	$2,150,263	148,294	-38.0%	Shares	Sole	2024-11-14
2024-06-30	$2,035,540	239,194	0.0%	Shares	Sole	2024-08-14
2024-03-31	$2,444,562	239,194	-23.1%	Shares	Sole	2024-05-15
2023-12-31	$1,705,206	311,169	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.